financetom
Market
financetom
/
Market
/
US Equity Indexes Nudge Higher as Investors Eye Nvidia's Post-Bell Q2 Earnings
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Equity Indexes Nudge Higher as Investors Eye Nvidia's Post-Bell Q2 Earnings
Aug 27, 2025 9:45 AM

12:24 PM EDT, 08/27/2025 (MT Newswires) -- US equity indexes edged up in midday trading on Wednesday ahead of Nvidia's ( NVDA ) Q2 results after the bell.

The Dow Jones Industrial Average climbed 0.2% to 45,523.1, with the S&P 500 up 0.2% to 6,480.2 and the Nasdaq Composite 0.2% higher at 21,589.5. Energy was the top gainer intraday, followed by technology, real estate, and financials.

Nvidia ( NVDA ) is expected to report non-GAAP earnings of $1.01 per share and revenue of $46.05 billion for fiscal Q2, according to analysts surveyed by FactSet.

"Expectations are high after a rapid run in (artificial intelligence) spending," Ruben Dalfovo, investment strategist at Saxo Bank, said in a Tuesday note. "Nvidia ( NVDA ) is now the largest weight in the S&P 500 at roughly 8%, so its guidance can sway broad portfolios."

Treasury yields traded mixed, with the two-year yield down 3.4 basis points to 3.64% while the 10-year rate climbed 1.5 basis points to 4.27%, steepening the yield curve between the two maturities.

West Texas Intermediate crude oil futures jumped 1% to $63.86 a barrel.

Excluding inventories in the Strategic Petroleum Reserve, US commercial crude oil stocks fell by 2.4 million barrels in the week ended Aug. 22 after a 6-million-barrel decline in the previous week, versus the 2-million-barrel decrease expected in a survey compiled by Bloomberg.

In company news, Accenture ( ACN ) agreed to acquire NeuraFlash, a Salesforce ( CRM ) consulting partner, for an undisclosed sum. Shares of Salesforce ( CRM ) were up 2.1% intraday, the Dow's top performer.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved